CALIDI BIOTHERAPEUTICS, INC.

Insiders Calidi Biotherapeutics, Inc.

Equities

CLDI

US3207031010

Market Closed - Nyse Other stock markets 04:00:00 2024-05-01 pm EDT			5-day change	1st Jan Change
0.193 ^USD	-1.03%		+22.23%	-87.22%

Apr. 16	Calidi Biotherapeutics Prices $6.1 Million Offering	MT
Mar. 21	H.C. Wainwright Lowers Price Target on Calidi Biotherapeutics to $2 From $11, Maintains Buy Rating	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Calidi Biotherapeutics, Inc. Announces Scientific and Medical Advisory Board Appointments	Jan. 08	CI
Calidi Biotherapeutics Announces Directorate Changes	Dec. 12	CI
Calidi Biotherapeutics, Inc. Announces the Resignation of Alfonso Zulueta as A Director, Including His Position on Audit Committee of the Board	Dec. 05	CI
Calidi Biotherapeutics, Inc. Announces Key Leadership Promotions and New Board Appointment	Nov. 01	CI
Calidi Biotherapeutics Names Andrew Jackson as Chief Financial Officer	23-10-30	MT
Calidi Biotherapeutics, Inc. Announces Resignation of Tony Kalajian as Interim Chief Financial Officer	23-10-27	CI
Calidi Biotherapeutics, Inc. Announces Resignation of Tony Kalajian as Chief Accounting Officer	23-10-27	CI
Calidi Biotherapeutics, Inc. Appoints Alan R. Stewart as the Class I Director	23-10-24	CI
Calidi Biotherapeutics, Inc. Announces the Resignation of Dr. Heehyoung Lee, Including All Her Positions on the Committees of the Board	23-10-16	CI
First Light Acquisition Group's co-CEO Bill Weber Steps Down	22-12-27	MT
First Light Acquisition Group, Inc. Announces Resignation of Bill Weber as Co-Chiefexecutive Officer, Director and Chairman of the Board of Directors	22-12-27	CI
First Light Acquisition Group, Inc. Announces Executive Changes	22-09-16	CI
First Light Acquisition Group Shareholders Approve Merger Date Extension; Tom Vecchiolla Named Co-CEO	22-09-16	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer